Literature DB >> 857097

Aspects of British general practitioners' prescribing.

R Mapes.   

Abstract

Some criteria for the rational prescribing of pharmaceuticals were considered in relationship to the prescribing of a sample of British general practitioners. In particular, interest was focused on the criteria of effectiveness and safety in what is prescribed. Actual prescriptions were examined for one complete given month and the physicians writing these were judged on the criteria, using carefully specified definitions. Next the professional, educational, and demographic characteristics of the selected physicians were examined and an attempt was made to account for the manner in which physicians were judged on the two rationality criteria in terms of these characteristics. Ninety characteristics were originally considered. In the event it was shown that a reasonable discrimination of physicians' prescribing could be made on the basis of five such characteristics.

Mesh:

Year:  1977        PMID: 857097     DOI: 10.1097/00005650-197705000-00003

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  7 in total

1.  A sample argument.

Authors:  J Lexchin
Journal:  CMAJ       Date:  1991-01-15       Impact factor: 8.262

2.  Pill-takers: At Special Risk Of Chlamydial Infection?

Authors:  J McSherry
Journal:  Can Fam Physician       Date:  1986-01       Impact factor: 3.275

3.  Prescribing by canadian general practitioners: review of the english language literature.

Authors:  J Lexchin
Journal:  Can Fam Physician       Date:  1990-03       Impact factor: 3.275

4.  Introducing a new drug: an objection.

Authors:  J Lexchin
Journal:  Can Fam Physician       Date:  1988-05       Impact factor: 3.275

5.  Consequences of direct-to-consumer advertising of prescription drugs.

Authors:  J Lexchin
Journal:  Can Fam Physician       Date:  1997-04       Impact factor: 3.275

6.  A cross-sectional evidence-based review of pharmaceutical promotional marketing brochures and their underlying studies: is what they tell us important and true?

Authors:  Roberto Cardarelli; John C Licciardone; Lockwood G Taylor
Journal:  BMC Fam Pract       Date:  2006-03-03       Impact factor: 2.497

7.  What do Libyan doctors perceive as the benefits, ethical issues and influences of their interactions with pharmaceutical company representatives?

Authors:  Mustafa Ali Alssageer; Stefan Robert Kowalski
Journal:  Pan Afr Med J       Date:  2013-04-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.